O’Regan on Protocols, Best Practices, and Virtual Etiquette for Cancer Care in Light of COVID-19

In Partnership With:

Partner | Cancer Centers | <b>University of Wisconsin Carbone Cancer Center</b>

In our exclusive interview, O’Regan discusses the protocols the University of Wisconsin Carbone Cancer Center has put into place in light of COVID-19, the rise of telemedicine, best practices for in-person visits in the clinic, and the importance of maintaining well visits throughout the pandemic.

Welcome to a very special edition of OncLive® On Air! I’m your host today, Caroline Seymour.

OncLive® On Air is a podcast from OncLive, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. 

Today, we had the pleasure of speaking with Ruth O’Regan, MD, professor and division head of Hematology and Oncology in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, and associate director of Clinical Research at the University of Wisconsin Carbone Cancer Center, to discuss the impact of the coronavirus disease 2019 (COVID-19) on clinical practice.

The COVID-19 pandemic has affected more than 33 million people worldwide, and for patients with cancer, the pandemic has forced health care systems across the globe to adapt traditional care continuums.

In our exclusive interview, O’Regan discussed the protocols the University of Wisconsin Carbone Cancer Center has put into place in light of COVID-19, the rise of telemedicine, best practices for in-person visits in the clinic, and the importance of maintaining well visits throughout the pandemic.